2. Statistics Canada: Tuberculosis Statistics, 1990. Health Reports 1992; 4(2 Suppl 10)

3. Screening for tuberculosis and tuberculous infection in high-risk populations. The use of preventative therapy for tuberculous infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39(RR-8): 1-12

4. Longfield JN, Margileth AM, Golden SM, et al: Interobserver and method variability in tuberculin skin testing. Pediatr Infect Dis 1984; 3(4): 323-326

5. Curry FJ: Prophylactic effect of isoniazid in young tuberculin reactors. New Engl J Med 1967; 277(11): 562-567

6. Ferebee SH, Mount FW, Murray FJ, et al: A controlled trial of isoniazid prophylaxis in mental institutions. Am Rev Respir Dis 1963; 88(2): 161-17

7. American Thoracic Society: Control of tuberculosis in tyhe United States. Am Rev Respir Dis 1992; 146: 1623-1633

8. Pape JW Jean SS, Ho JL: Effect of isoniazid prophylaxis on the incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-72

9. Mount FW, Ferebee SH: The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis. Am Rev Respir Dis 1962; 85: 821-827

10. Bush O, Sigimoto M, Fujii Y, et al: Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second Report. Am Rev Respir Dis 1965; 92: 732-740

11. Veening GJ: Long term isoniazid prophylaxis: Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull Un Int Tuberc 1968; 41: 169-171

12. Stead WW, Lofgren JP, Warren E, et al: Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. New Engl J Med 1985; 312(23): 1483-1487

13. International Union Against Tuberculosis Committee on Prophylaxis: Efficacy of various durations of isoniazid preventative therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organization 1982; 60(4): 555-564

14. Snider DE Jr., Caras GJ, Koplan JP: Preventative therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA 1986; 255: 1579-1583

15. Wobeser W, To T, Hoeppner VH: The outcome of chemoprophylaxis on tuberculosis prevention in the Canadian Plains Indian. Clin Invest Med 1989; 12(3): 149-153

16. Kopanoff DE, Snider DE, Caras GJ: Isoniazid-related hepatitis: A US Public Health Service Cooperative Surveillance study. Am Rev Respir Dis 1978; 117: 991-1001

17. Prevention and control of tuberculosis in US communities with at-risk minority populations. Prevention and control of tuberculosis among homeless persons. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1992; 41(RR-5): 1-23

18. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services: an Assessment of the Effectiveness of 169 Interventions. Williams & Wilkins, Baltimore, Md, 1989: 125-128, 370-372

19. Peter G (Ed): Report of the Committee of Infectious Diseases. 22nd Edition, American Academy of Pediatrics, 1991